- Home
- FGEN vs MDCX Comparison
FGEN vs MDCX Comparison
Compare FGEN & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGEN
- MDCX
- Stock Information
- Founded
- FGEN 1993
- MDCX 2008
- Country
- FGEN United States
- MDCX United States
- Employees
- FGEN N/A
- MDCX N/A
- Industry
- FGEN Biotechnology: Pharmaceutical Preparations
- MDCX
- Sector
- FGEN Health Care
- MDCX
- Exchange
- FGEN Nasdaq
- MDCX Nasdaq
- Market Cap
- FGEN 45.0M
- MDCX 50.8M
- IPO Year
- FGEN 2014
- MDCX N/A
- Fundamental
- Price
- FGEN $10.38
- MDCX $2.36
- Analyst Decision
- FGEN Strong Buy
- MDCX Strong Buy
- Analyst Count
- FGEN 2
- MDCX 2
- Target Price
- FGEN $146.50
- MDCX $23.50
- AVG Volume (30 Days)
- FGEN 29.2K
- MDCX 378.0K
- Earning Date
- FGEN 11-11-2025
- MDCX 11-22-2025
- Dividend Yield
- FGEN N/A
- MDCX N/A
- EPS Growth
- FGEN N/A
- MDCX N/A
- EPS
- FGEN N/A
- MDCX N/A
- Revenue
- FGEN $7,346,000.00
- MDCX N/A
- Revenue This Year
- FGEN N/A
- MDCX N/A
- Revenue Next Year
- FGEN N/A
- MDCX N/A
- P/E Ratio
- FGEN N/A
- MDCX N/A
- Revenue Growth
- FGEN N/A
- MDCX N/A
- 52 Week Low
- FGEN $4.50
- MDCX $1.79
- 52 Week High
- FGEN $21.94
- MDCX $8.94
- Technical
- Relative Strength Index (RSI)
- FGEN 39.54
- MDCX 49.17
- Support Level
- FGEN $10.29
- MDCX $2.33
- Resistance Level
- FGEN $11.24
- MDCX $2.48
- Average True Range (ATR)
- FGEN 0.61
- MDCX 0.19
- MACD
- FGEN -0.18
- MDCX -0.02
- Stochastic Oscillator
- FGEN 5.07
- MDCX 38.46
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.
About MDCX Medicus Pharma Ltd. Common Stock
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.